Supplemental Data - Dudink et al. JAAD; 2022

Published: 10 May 2022| Version 3 | DOI: 10.17632/87zwhv6gxd.3
Contributor:

Description

Supplemental Data - Dudink et al. Guselkumab for Hidradenitis Suppurativa: a phase II, open label, mode of action study. JAAD; 2022.

Files

Institutions

Erasmus Universiteit Rotterdam

Categories

Dermatology

Licence